Key result
Mesalamine-induced myopericarditis resolves completely following prompt drug withdrawal.
Why the study?
Myopericarditis has occasionally been reported as a side effect of mesalamine in patients with inflammatory bowel disease, but clinical awareness remains limited.
Does mesalamine withdrawal lead to recovery of myopericarditis in patients with inflammatory bowel disease?
Case Report (n=1)
Does mesalamine withdrawal lead to recovery of myopericarditis in patients with inflammatory bowel disease?
Mesalamine can cause myopericarditis in patients with inflammatory bowel disease, which resolves upon drug withdrawal.
Answers are grounded in this paper and cite their sources.
May warrant considering mesalamine withdrawal in IBD patients with myopericarditis; single case leaves causality and generalizability open.
Myopericarditis has occasionally been reported as a side effect of mesalamine in patients with inflammatory bowel disease. We present a 20-year-old woman with ulcerative colitis admitted with chest pain. After thorough investigation she was diagnosed with myopericarditis potentially related to mesalamine. There was complete clinical and laboratorial recovery following drug withdrawal. Although uncommon, the possibility of myopericarditis should be considered in patients with inflammatory bowel disease presenting with cardiac complaints. Early recognition can avoid potential life-threatening complications.
No takes yet. Share an insight, caveat, or question.
Bernardo et al. (2016) conducted a case report in Ulcerative colitis and myopericarditis (n=1). Mesalamine was evaluated on Clinical and laboratorial recovery. Mesalamine exposure in a 20-year-old woman with ulcerative colitis was associated with myopericarditis, which completely resolved following drug withdrawal.
Synapse has enriched 10 related papers. Consider them for comparative context: